Hypercalcaemia complicating polyneuropathy.
نویسندگان
چکیده
منابع مشابه
Immobilisation hypercalcaemia complicating polyneuropathy in adolescent boys.
Two boys who were immobilised with peripheral neuropathy developed hypercalcaemia. It is suggested that hypercalcaemia aggravated the muscle weakness as well as producing systemic upset. The hypercalcaemia was controlled with corticosteroids which had to be continued over several months. A satisfactory remission of the disease occurred in both cases. The hypercalcaemia was attributed to immobil...
متن کاملPolyneuropathy and Cerebral Infarction Complicating Scrub Typhus
We describe a 64-year-old man with scrub typhus who presented with both polyneuropathy and cerebral infarction. A eurological examination revealed a confused mental state, stiff neck, hearing impairment, symmetric weakness, sensory loss, and ataxia. Electrophysiologic studies showed demyelinating sensorimotor polyneuropathy and sensorineural hearing loss. Brain magnetic resonance imaging showed...
متن کاملChronic relapsing inflammatory polyneuropathy complicating sicca syndrome.
although the latter is more potent and has a isolated caudate slices by one minute longer plasma half-life.3 exposure to 20mM K' induced a tritium Given their mild D2 blocking effect in overflow of 3-9% of tissue content. Cinnaaddition to their calcium entry channe. rizine, flunarizine and nifedipine at doses antagonist activity, it has been speculated able to block calcium channels lowered the...
متن کاملSevere polyneuropathy complicating active Crohn’s disease: rapid response to Infliximab
Treatment with a chimeric antitumour necrosis factor (TNF) antibody (Infliximab) has been shown to be highly efficient for patients with steroid refractory Crohn’s disease (CD). However, the mechanism of action remains largely unknown. Recently, a favourable response to Infliximab treatment was demonstrated in some diseases complicating active CD such as acute idiopathic pancreatitis. We report...
متن کاملSevere polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.
Treatment with a chimeric antitumour necrosis factor (TNF) antibody (Infliximab) has been shown to be highly efficient for patients with steroid refractory Crohn’s disease (CD). However, the mechanism of action remains largely unknown. Recently, a favourable response to Infliximab treatment was demonstrated in some diseases complicating active CD such as acute idiopathic pancreatitis. We report...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 1985
ISSN: 0022-3050
DOI: 10.1136/jnnp.48.4.390-a